Skip to main content
. 2016 Nov 10;10(4):461–469. doi: 10.1093/ckj/sfw101

Fig. 1.

Fig. 1.

Infections observed within 12 months after rituximab therapy. HSV, herpes simplex virus; VZV, varicella zoster virus. *HSV/VZV infections were HSV stomatitis, HSV genital infection and two zoster recurrences. **Miscellaneous infections were pulmonary aspergillosis, invasive candidiasis and cytomegalovirus viremia.